Aberrant p16 methylation is a biomarker for tobacco exposure in cervical squamous cell carcinogenesis

Jayanthi S. Lea, Robert Coleman, Aleena Kurien, John O. Schorge, David S. Miller, John D. Minna, Carolyn Y. Muller

Research output: Contribution to journalArticlepeer-review

45 Scopus citations

Fingerprint

Dive into the research topics of 'Aberrant p16 methylation is a biomarker for tobacco exposure in cervical squamous cell carcinogenesis'. Together they form a unique fingerprint.

Medicine & Life Sciences